Shikiar Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-6,045
| Closed | -$219K | – | 114 |
|
|
2016
Q4 | $219K | Sell |
6,045
-15,325
| -72% | -$555K | 0.1% | 95 |
|
|
2016
Q3 | $983K | Buy |
21,370
+4,475
| +26% | +$206K | 0.44% | 45 |
|
|
2016
Q2 | $849K | Buy |
16,895
+11,095
| +191% | +$558K | 0.38% | 43 |
|
|
2016
Q1 | $310K | Buy |
5,800
+300
| +5% | +$16K | 0.14% | 90 |
|
|
2015
Q4 | $361K | Hold |
5,500
| – | – | 0.17% | 58 |
|
|
2015
Q3 | $311K | Sell |
5,500
-2,000
| -27% | -$113K | 0.16% | 65 |
|
|
2015
Q2 | $443K | Hold |
7,500
| – | – | 0.2% | 66 |
|
|
2015
Q1 | $467K | Hold |
7,500
| – | – | 0.2% | 69 |
|
|
2014
Q4 | $431K | Sell |
7,500
-700
| -9% | -$40.2K | 0.2% | 78 |
|
|
2014
Q3 | $441K | Sell |
8,200
-3,000
| -27% | -$161K | 0.19% | 77 |
|
|
2014
Q2 | $587K | Sell |
11,200
-2,000
| -15% | -$105K | 0.24% | 76 |
|
|
2014
Q1 | $697K | Sell |
13,200
-7,500
| -36% | -$396K | 0.31% | 66 |
|
|
2013
Q4 | $830K | Sell |
20,700
-15,950
| -44% | -$640K | 0.36% | 56 |
|
|
2013
Q3 | $1.39M | Sell |
36,650
-9,600
| -21% | -$363K | 0.69% | 43 |
|
|
2013
Q2 | $1.81M | Buy |
+46,250
| New | +$1.81M | 0.9% | 37 |
|